ALX Oncology Holdings, Inc. (ALXO)
1.47
+0.03
(+2.08%)
USD |
NASDAQ |
Dec 09, 16:00
1.41
-0.06
(-4.08%)
After-Hours: 07:51
ALX Oncology Holdings Total Assets (Quarterly): 82.72M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 4.852B |
| Prelude Therapeutics, Inc. | 94.76M |
| Werewolf Therapeutics, Inc. | 79.63M |
| Erasca, Inc. | 420.40M |
| Immuneering Corp. | 241.06M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 37.92M |
| Shareholders Equity (Quarterly) | 44.80M |
| Debt to Equity Ratio | 0.3484 |
| Current Ratio | 2.399 |
| Net Debt Paydown Yield | 0.38% |